Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

Presentation TCT 2016

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? Stop Wasting Valuable Time Go Straight to LVAD/Transplant!

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Nir Uriel

October 30, 2016

Presentation TCT 2016

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? MitraClip Should Always Be Considered First!

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Saibal Kar

October 30, 2016

News Daily News

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Michael O'Riordan

October 17, 2016

News Daily News

Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES

Caitlin E. Cox

August 17, 2016

News Daily News

Palliative Care Is Sorely Underused for Patients With Severe Heart Failure

Caitlin E. Cox

July 11, 2016

News Daily News

Imagining the Unimaginable: Video May Help Heart Failure Patients With End-of-Life Decisions

Leah Lawrence

July 07, 2016

News Daily News

FDA Warns of Class I Recall for HeartWare VAD Batteries

Michael O'Riordan

June 29, 2016

News Industry News

HeartWare Completes Enrollment In HVAD® System LATERAL Study™

April 28, 2016

News Conference News AHA 2015

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

Todd Neale

November 08, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Amit Patel

October 15, 2015

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Daily News

ICDs Often Not Given to Older Patients After Acute MI, Outcomes Suffer

Todd Neale

June 25, 2015

News Opinion Fellow Talk

‘Absence of Evidence Is Not the Evidence of Absence’ - How Do We Translate Clinical Research Into Clinical Practice?

Gagan Singh, MD

January 26, 2015

News Daily News

Chronic Vitamin K Antagonist Use Ups In-Hospital Bleeding Among Primary PCI Patients

Caitlin E. Cox

November 02, 2014

News Daily News

First-in-Human Transcatheter Mitral Valve Replacement Cases Show Safety, Efficacy

Yael L. Maxwell

October 24, 2014

News Industry News

New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients

September 15, 2014

Advertisement

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? Stop Wasting Valuable Time Go Straight to LVAD/Transplant!

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? MitraClip Should Always Be Considered First!

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES

Palliative Care Is Sorely Underused for Patients With Severe Heart Failure

Imagining the Unimaginable: Video May Help Heart Failure Patients With End-of-Life Decisions

FDA Warns of Class I Recall for HeartWare VAD Batteries

HeartWare Completes Enrollment In HVAD® System LATERAL Study™

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

ICDs Often Not Given to Older Patients After Acute MI, Outcomes Suffer

‘Absence of Evidence Is Not the Evidence of Absence’ - How Do We Translate Clinical Research Into Clinical Practice?

Chronic Vitamin K Antagonist Use Ups In-Hospital Bleeding Among Primary PCI Patients

First-in-Human Transcatheter Mitral Valve Replacement Cases Show Safety, Efficacy

New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content